Clinical trial laboratory principles for emerging infectious disease research in resource-limited settings.

Authors

Daniel Mukadi-Bamuleka, Kathryn Shaw-Saliba, Emily Yox, Michael Kombozi Basika, Nadeeka Randunu, Nella Bisento, Amie Jarra, Tina Bakutumba, Sara Zufan, Michel Ngimba, Dido Mpungu, Grace Kilonda Pela, Lebon Matendo, Nsengi Ntamabyaliro, H Clifford Lane, Placide Mbala-Kingebeni, Richard Davey, Jens H Kuhn, Ian Crozier, Lori E Dodd, Olivier Tshiani Mbaya, Veronique Nussenblatt, Irina Maljkovic Berry

Published in

Trends open. Aug 22, 2026. Epub Aug 22, 2026.

Abstract

For emerging and re-emerging viral diseases, the timing and location of outbreaks are typically unpredictable and may require rapid implementation of randomized controlled trials (RCTs) to evaluate safety and efficacy of candidate vaccines or therapeutics. In austere and hard-to-reach settings, establishing effective laboratory operations for RCTs requires considerable effort to address both anticipated and unforeseen challenges. Here, we describe key principles and practical challenges associated with effective research laboratory operationalization in the context of a double-blinded, placebo-controlled RCT for evaluation of an mpox candidate therapeutic in the Democratic Republic of the Congo. The solutions implemented and lessons learned may inform the planning and operationalization of clinical trial laboratories in resource-limited outbreak settings and provide a framework to guide future efforts.

PMID:
42836097
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.